Home > Use of Xofigo in mCRPC. Preview of a Belgian multidisciplinary consensus publication
<< Back to the News

Use of Xofigo in mCRPC. Preview of a Belgian multidisciplinary consensus publication

Published on 04.04.2018

Dear colleagues, you are cordially invited to regional meetings organised by Bayer with the aim of discussing the use of Xofigo in mCRPC patients and presenting the results of a multidisciplinary consensus about sequences of available treatments for mCRPC patients with a focus on Xofigo.

    One meeting is confirmed in Leuven on the 18th of April

 

Sincerely,

the BELNUC board.

 

 

Xofigo_Avril 2018_Programme.pdf
Download the document